U.S. Residential REITs Stock News

Eisai and Biogen announced in early October that the U.S. launch of LEQEMBI IQLIK, a subcutaneous autoinjector formulation for Alzheimer’s disease, has begun, with the product receiving approval in August and being recognized as one of TIME’s Best Inventions of 2025. This new formulation offers patients an at-home alternative to intravenous treatment, aiming to ease access and expand treatment capacity for early-stage Alzheimer’s disease, while a companion app and patient support program...

VICI Properties is entering a new 25-year lease for Northfield Park with Clairvest, while also amending its master lease with MGM Resorts. This move secures stable rent income and manages the transition as MGM divests operations. See our latest analysis for VICI Properties. Shares of VICI Properties are up 6.5% so far in 2025, though the 1-year total shareholder return sits slightly in the red at -1.8%. These numbers reflect a year of steady, if unspectacular, momentum as VICI navigates major...

Cirrus Logic (CRUS) shares saw movement today following investor reactions to the company’s recent trading activity and performance updates. Many are looking at how its valuation shapes up in light of the latest developments in the semiconductor sector. See our latest analysis for Cirrus Logic. Cirrus Logic’s share price has gathered momentum, climbing 9.05% over the last week and up 22.04% in the past three months, signaling a noticeable shift in sentiment among investors. Despite only a...

In recent days, concerns over regional bank loan quality intensified after Zions Bancorp disclosed a US$50 million charge-off and Western Alliance Bancorp reported problems with borrower collateral. This industry-wide unease has drawn particular attention to loan portfolio risks at similar banks, including United Bankshares. We’ll explore how heightened scrutiny of regional bank lending standards shapes United Bankshares’ investment narrative in the current climate. We've found 18 US stocks...

Caesars Entertainment (CZR) is back in focus after a wave of new analyst commentary sparked by its recent Q2 2025 earnings. The update revealed solid digital segment growth; however, analysts remain divided given ongoing challenges in the core Las Vegas market. See our latest analysis for Caesars Entertainment. Despite a wave of upbeat digital growth news, Caesars Entertainment’s share price tells a more cautionary tale, dropping over 15% in the past month, with its total shareholder return...

Upstream Bio (UPB) recently made headlines after presenting fresh structural and mechanistic insights for its promising drug candidate, verekitug, at a major scientific congress. This event has drawn renewed investor attention to the company. See our latest analysis for Upstream Bio. Following the buzz around verekitug’s data, Upstream Bio’s share price has shown real momentum, up nearly 31% over the past month and a striking 96% in the last 90 days. But it’s worth noting the total...

If you have been watching AES lately and wondering whether now is the time to make a move, you are not alone. The past few weeks have been anything but boring for this power company, and the stock has been catching the eye of analysts, investors, and anyone following major infrastructure news. Just look at the numbers, with AES jumping 3.6% in the last week and a powerful 16.5% over the past month. That is a massive reversal from where it stood a year ago, down 11.6%, and the company is still...

Oracle’s (ORCL) latest string of announcements put its long-term growth strategy in the spotlight. After raising revenue and margin targets on the back of multi-year cloud infrastructure agreements with companies like Meta and OpenAI, the company has investors debating how achievable these ambitions really are. See our latest analysis for Oracle. Oracle’s latest earnings call and blockbuster cloud contracts have certainly shaken things up. After a massive 75% share price return so far this...

Recent discussion around Five9 (FIVN) points to weak billings growth and softening future sales projections. Such signals often spark fresh investor interest as the market weighs what these changes could mean for Five9's longer-term prospects. See our latest analysis for Five9. Five9’s share price return has struggled lately, declining 16.9% over the past month and down nearly 47% year-to-date, as cautious investor sentiment builds around slowing growth. Over the past year, the total...

Alkermes (ALKS) shares have seen some movement recently, catching the attention of investors tracking the biotech sector. Over the past month, the stock has gained 9% as market participants weigh its recent performance and underlying fundamentals. See our latest analysis for Alkermes. Alkermes’ share price continues to show signs of growing investor confidence, with a one-month share price return of nearly 9% adding to the gradual upward trend over the year. Looking at the bigger picture, the...

Thinking about whether to hold on to, scoop up, or pass on Silicon Motion Technology stock? You are not alone. Investors have been closely watching the market, and Silicon Motion has delivered an impressive set of returns that are hard to ignore. Over just the past week, the stock jumped by 9.7%, bringing its gains over the last month to 6.4%. If you zoom out, the numbers get even more eye-catching: the company has climbed 72.3% year-to-date and 74.2% in the last year, with a remarkable...

Analog Devices recently announced the launch of ADI Power Studio, a comprehensive suite of web-based tools designed to streamline power system design and accelerate engineers’ development cycles. This initiative highlights the company’s drive to integrate advanced modeling, efficiency analysis, and guided workflows, giving engineers expanded capabilities for power-dense system applications. We'll explore how the new ADI Power Studio tools could enhance Analog Devices' long-term edge in...

Caledonia Mining Corporation Plc recently announced that Allan Gray Bermuda Limited’s clients’ aggregate shareholding fell below 3% of its total issued shares, now standing at 2.9303% as of 13 October 2025. This change in shareholding structure highlights shifts in institutional investor strategies and could influence the company’s market dynamics and investor relations. We’ll explore how this reduction in a key institutional shareholder’s stake may affect Caledonia Mining’s investment...

Fox Advertising and Mobian recently announced a partnership to advance data-driven advertising and content optimization across the FOX portfolio, beginning with FOX News Media, leveraging AI-powered tools for real-time ad activation and post-campaign measurement. This collaboration highlights how AI-based audience insight and creative intelligence are shaping a more unified and effective approach to advertising, especially as Fox expands its digital capabilities with new platforms like 'Fox...

Extra Space Storage (EXR) has been under the microscope after its Q2 update revealed lower-than-expected core FFO and a drop in same-store NOI. This has prompted management to tighten its 2025 outlook. With the company now forecasting flat-to-negative revenue growth and potential NOI declines, investors are keeping a close eye on the upcoming Q3 earnings. See our latest analysis for Extra Space Storage. Extra Space Storage’s share price took a sharp hit in late July after the company reported...

Tractor Supply (TSCO) shares have been relatively steady lately, even as many retail names have seen some volatility. Over the past month, the stock is down about 7%, which may catch investors’ attention. See our latest analysis for Tractor Supply. While Tractor Supply’s 1-month share price return of -6.6% might raise eyebrows, the company’s long-term story is a bit brighter, with a 3-year total shareholder return of 47% and an impressive 5-year figure above 110%. Recent price dips could...

Earlier this week, several major banks released third-quarter results surpassing Wall Street expectations, highlighted by strong investment banking and trading performance, while Fed Chair Jerome Powell indicated the Federal Reserve could soon halt quantitative tightening, fueling optimism about increased market liquidity. This combination of robust big bank earnings and hints of easier monetary policy created a ripple effect, driving positive sentiment throughout the regional banking sector...

On October 8, 2025, Ascendis Pharma announced it had submitted a Marketing Authorisation Application to the European Medicines Agency for TransCon CNP as a treatment for children with achondroplasia, a rare genetic disorder affecting bone growth and quality of life. This regulatory milestone highlights Ascendis Pharma’s ongoing efforts to address significant unmet medical needs in pediatric rare diseases through its TransCon platform. We'll examine how progress toward European approval for...

Florida State University recently announced its selection of GeneDx as a partner for the first statewide, state-backed genomic newborn screening program under the Sunshine Genetics Act, aiming to provide whole-genome sequencing to 100,000 newborns over five years for early rare disease detection. This milestone positions GeneDx at the forefront of integrating genomics into routine pediatric care, signaling a substantial shift in public health policy and the scale of genetic testing...

If you’re holding Applied Materials or considering a buy, you’re probably asking yourself the same thing as everyone else: how much higher can this stock go? It seems like every month brings another reason for investors to pay attention, with the company’s share price up an impressive 7.2% over just the past week, 26.3% in the last month, and a staggering 37.3% year-to-date. Even stretching back five years, Applied Materials has delivered a jaw-dropping 285.9% return, handily outpacing the...

Earlier this week, the White House proposed a policy to make in vitro fertilization (IVF) more accessible, encouraging employers to offer IVF and infertility coverage as standalone benefits without federal funding or mandatory participation. This initiative could prompt employers to expand infertility treatment offerings and may serve as a catalyst for companies specializing in fertility benefits, such as Progyny, given their established presence and expertise in the sector. We'll look at...

Coty recently wrapped up a substantial $900 million private offering of 5.6% senior notes due 2031. The company is redirecting proceeds to refinance existing debt and cover related expenses. This move demonstrates Coty's focus on liability management and financial flexibility. See our latest analysis for Coty. Coty’s fresh approach to its capital structure seems to be resonating with investors, as shown by the 4.58% jump in the share price over the last day and a 3.58% rise in the past week...

On October 8, 2025, NRG Energy completed the private placement of US$625 million secured notes due 2030, US$625 million secured notes due 2035, US$1.25 billion unsecured notes due 2034, and US$2.40 billion unsecured notes due 2036, with proceeds to fund acquisitions and debt repayment. This significant debt financing supports NRG's acquisition of multiple power assets and highlights its ongoing approach to portfolio expansion and capital structure management. We'll examine how NRG's sizable...

CSX (CSX) reported net profit margins of 20.5%, down from 24.7% last year. The company noted that earnings have grown by an average of just 0.8% per year over the past five years. Forward-looking estimates put annual earnings growth at 9.47% and revenue growth at 4%. Both figures trail the averages for the US market and the transportation sector. With margins narrowing and recent results showing negative earnings growth in the past year, investor focus will likely remain on how profit trends...